Positive Marijuana Research Database
The Cannabis Access for Medical Purposes Survey is a 414-question cross-sectional survey that was completed by 473 adults who use cannabis (marijuana) for therapeutic purposes between 2011-2012. This study examines the use of cannabis as a substitute for alcohol, illicit substances and prescription drugs. Substituting medical marijuana for one of the above substances was reported […]
Using data on all prescriptions filled by Medicare Part D enrollees from 2010 to 2013, the authors of this study found that the use of prescription drugs for which marijuana (cannabis) could serve as a clinical alternative fell significantly, once a medical marijuana law was implemented. National overall reductions in Medicare program and enrollee spending […]
It has been questioned if cannabis (marijuana) users have any impairment in healing following traumatic injury. This study used a retrospective chart review over a 2 year period from a Level I trauma center on patients having a toxicology report and a Injury Severity Score of more than 16. Differences in presenting characteristics, hospital length […]
The use of medical marijuana (cannabis) is continually increasing and it is most commonly used for pain, anxiety and depression. New information suggests that use and abuse of prescription drugs is decreasing where marijuana laws have been enacted. In this study, 2,774 individuals who reported using marijuana at least once in the previous 90 days, […]
Multiple sclerosis is an autoimmune disease leading to the destruction of myelin and nerve degeneration resulting in severe physical debilitation. Myelin surrounds the nerve similar to plastic surrounding an electrical wire. The disease can be treated with immunosuppressive drugs that alleviate the symptoms and slow disease aggravation. One of those drugs currently in clinical use […]
In this small study, 31 patients were observed who had been screened, and treated with standard medical pain control consisting of: 5 mg of oxycodone hydrochloride equivalent to 4.5 mg oxycodone and 2.5 mg naloxone hydrochloride twice a day and duloxetine 30 mg once a day. After following this regimen for 3 months, the participants […]